Scholar Rock Holding (SRRK) Shares Outstanding (Diluted Average) (2020 - 2026)

Scholar Rock Holding (SRRK) recorded quarterly Shares Outstanding (Diluted Average) of $127.3 million in Q1 2026, up 10.96% quarter-over-quarter from $114.7 million in Q4 2025, and up 13.8% on a YoY basis from $111.8 million in Q1 2025.

Scholar Rock Holding (SRRK) Shares Outstanding (Diluted Average) (2020 - 2026) Analysis & Trends

Scholar Rock Holding's Shares Outstanding (Diluted Average) history runs 7 years deep, the most recent figure standing at $127.3 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Diluted Average) rose 13.8% year-over-year to $127.3 million; the TTM figure through Mar 2026 stood at $127.3 million (up 13.8% YoY), while the FY2025 annual figure was $114.7 million, up 14.89% from the prior year.
  • Shares Outstanding (Diluted Average) was $127.3 million for Q1 2026 at Scholar Rock Holding, up from $114.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $127.3 million in Q1 2026 to a low of $37.5 million in Q1 2022.
  • Historically, Shares Outstanding (Diluted Average) has averaged $87.1 million across 5 years, with a median of $95.9 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) gained 2.96% in 2022, then soared 112.54% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $59.6 million in 2022, then surged by 39.82% to $83.3 million in 2023, then advanced by 19.79% to $99.8 million in 2024, then advanced by 14.89% to $114.7 million in 2025, then gained by 10.96% to $127.3 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $127.3 million (Q1 2026), $114.7 million (Q4 2025), and $112.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 Scholar Rock Holding 6.03 Bn 5.55 Bn - 127.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 127.28 Mn
Dec 31, 2025 114.70 Mn
Sep 30, 2025 112.76 Mn
Jun 30, 2025 112.27 Mn
Mar 31, 2025 111.84 Mn
Dec 31, 2024 99.84 Mn
Sep 30, 2024 96.59 Mn
Jun 30, 2024 96.81 Mn
Mar 31, 2024 95.89 Mn
Dec 31, 2023 83.35 Mn
Sep 30, 2023 80.12 Mn
Jun 30, 2023 79.87 Mn
Mar 31, 2023 79.61 Mn
Dec 31, 2022 59.61 Mn
Sep 30, 2022 52.96 Mn
Jun 30, 2022 39.55 Mn
Mar 31, 2022 37.46 Mn
Dec 31, 2021 36.71 Mn
Sep 30, 2021 36.55 Mn
Jun 30, 2021 36.48 Mn